Evidence map›Paper›PMID 25514898›Full record

ReviewEuropean journal of clinical nutrition2015

Vitamin D and thyroid disease: to D or not to D?

G Muscogiuri, G Tirabassi, G Bizzaro, F Orio, S A Paschou, A Vryonidou, G Balercia, Y Shoenfeld, A Colao

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in European journal of clinical nutrition, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 4 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 4 syntheses or guidelines pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 3 countries.

G MuscogiuriDepartment of Clinical Medicine and Surgery, Section of Endocrinology, University 'Federico II', Naples, Italy.
G TirabassiDivision of Endocrinology, Department of Clinical and Molecular Sciences, Umberto I Hospital, School of Medicine, Polytechnic University of Marche, Ancona, Italy.
G BizzaroThe Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.
F OrioDepartment of General Surgery and Transplantation Unit 'San Giovanni di Dio e Ruggi D'Aragona' University Hospital, Scuola Medica Salernitana, Salerno, Italy.
S A PaschouDepartment of Endocrinology and Diabetes, Hellenic Red Cross Hospital, Athens, Greece.
A VryonidouDepartment of Endocrinology and Diabetes, Hellenic Red Cross Hospital, Athens, Greece.
G BalerciaDivision of Endocrinology, Department of Clinical and Molecular Sciences, Umberto I Hospital, School of Medicine, Polytechnic University of Marche, Ancona, Italy.
Y Shoenfeld1] The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel [2] Incumbent of the Laura Schwarz-Kip Chair for Research of Autoimmune Diseases, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
A ColaoDepartment of Clinical Medicine and Surgery, Section of Endocrinology, University 'Federico II', Naples, Italy.
Federico II University Hospital · ITMarche Polytechnic University · ITHellenic Red Cross · GROspedali Riuniti San Giovanni di Dio e Ruggi d'Aragona · ITRed Cross Hospital · GRSheba Medical Center · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main role of vitamin D is to maintain calcium and phosphorus homeostasis, thus preserving bone health. Recent evidence has demonstrated that vitamin D may also have a role in a variety of nonskeletal disorders such as endocrine diseases and in particular type 1 diabetes, type 2 diabetes, adrenal diseases and polycystic ovary syndrome. Low levels of vitamin D have also been associated with thyroid disease, such as Hashimoto's thyroiditis. Similarly, patients with new-onset Graves' disease were found to have decreased 25-hydroxyvitamin D concentrations. Impaired vitamin D signaling has been reported to encourage thyroid tumorigenesis. This review will focus on the role of vitamin D in thyroid diseases, both autoimmune diseases and thyroid cancer, and will summarize the results of vitamin D supplementation studies performed in patients with thyroid disorders. Although observational studies support a beneficial role of vitamin D in the management of thyroid disease, randomized controlled trials are required to provide insight into the efficacy and safety of vitamin D as a therapeutic tool for this dysfunction.

Indexed as

Dietary SupplementsGraves DiseaseHashimoto DiseaseHumansThyroid DiseasesThyroid NeoplasmsVitamin DVitamin D DeficiencyVitaminsVitamin DVitamins

Identifiers

PMID25514898
OpenAlexW1573514753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.